Cargando…

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors

SIMPLE SUMMARY: This review describes that miR371 is much more sensitive and specific than the classical serum biomarkers of testicular germ cell cancer. There is a huge potential for miR371 for initial diagnosis, monitoring treatment, and follow-up. However, miR371 is not expressed in teratoma. Cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nestler, Tim, Schoch, Justine, Belge, Gazanfer, Dieckmann, Klaus-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417034/ https://www.ncbi.nlm.nih.gov/pubmed/37568759 http://dx.doi.org/10.3390/cancers15153944

Ejemplares similares

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
por: Belge, Gazanfer, et al.
Publicado: (2020)

Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor
por: Belge, Gazanfer, et al.
Publicado: (2020)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
por: Dieckmann, K-P, et al.
Publicado: (2012)

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
por: Radtke, A., et al.
Publicado: (2017)

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer
por: Regouc, Manuel, et al.
Publicado: (2020)

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
por: van Agthoven, Ton, et al.
Publicado: (2017)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas
por: Rippe, Volkhard, et al.
Publicado: (2010)

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males
por: Spiller, Cassy M., et al.
Publicado: (2020)

The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
por: Kremer, Lara, et al.
Publicado: (2021)

HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour
por: Kloth, Lars, et al.
Publicado: (2015)

MicroRNA-371-3 cluster as biomarkers for the diagnosis and prognosis of cancers
por: Pan, Bei, et al.
Publicado: (2019)

Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
por: Christiansen, Ailsa J., et al.
Publicado: (2022)

Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates—A Comprehensive Statistical Analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Refining the serum miR-371a-3p test for viable germ cell tumor detection
por: Lafin, John T., et al.
Publicado: (2023)

MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2016)

Comparative Analyses of Liquid-Biopsy MicroRNA371a-3p Isolation Protocols for Serum and Plasma
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
por: Myklebust, Mette Pernille, et al.
Publicado: (2021)

miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
por: Rosas Plaza, Ximena, et al.
Publicado: (2019)

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors
por: Schönberger, Stefan, et al.
Publicado: (2022)

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2018)

Clinical utility of plasma miR‐371a‐3p in germ cell tumors
por: Mego, Michal, et al.
Publicado: (2018)

Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
por: Lobo, João, et al.
Publicado: (2019)

Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range
por: Lafin, John, et al.
Publicado: (2023)

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
por: Lobo, João, et al.
Publicado: (2021)

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

FRI371 Serum Androstenedione As An Additive Biomarker In Ectopic Cushing’s Syndrome Evaluation
por: Zhang, Sherry, et al.
Publicado: (2023)

Molecular Mechanisms of Regulation and Action of microRNA-199a in Testicular Germ Cell Tumor and Glioblastomas
por: Gu, Shen, et al.
Publicado: (2013)

Diagnostic performance of microRNAs in testicular germ cell tumors: a systematic review and meta-analysis
por: Zhao, Xi-Yi, et al.
Publicado: (2021)

Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
por: Pratsinis, Manolis, et al.
Publicado: (2022)

Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors
por: Murray, Matthew J, et al.
Publicado: (2020)

The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
por: Salvatori, Daniela C.F., et al.
Publicado: (2018)

CPPED1-targeting microRNA-371a-5p expression in human placenta associates with spontaneous delivery
por: Daddali, Ravindra, et al.
Publicado: (2020)

German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures
por: Schoch, Justine, et al.
Publicado: (2023)

miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
por: De Martino, Marco, et al.
Publicado: (2021)

Editorial: Diagnostic and predictive biomarkers in testicular germ cell tumors
por: Lobo, João, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3t17iio4dlakto4u2h56c1hhi